Patents by Inventor Dagmar Kubitza

Dagmar Kubitza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF THROMBOPROPHYLAXIS
    Publication number: 20220193085
    Abstract: Methods of thromboprophylaxis using rivaroxaban is provided for children with congenital heart disease post-Fontan procedure.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 23, 2022
    Applicants: JANSSEN PHARMACEUTICALS, INC., BAYER PHARMA ATKIENGESELLSCHAFT
    Inventors: CHRISTOPHER NESSEL, Stefan Willmann, Dagmar Kubitza, Roger M. Mills, Catherine Vanden Boom, Elliot Barnathan, Liza Miriam Pina
  • Prevention and treatment of thromboembolic disorders
    Patent number: 9539218
    Abstract: The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less.
    Type: Grant
    Filed: January 19, 2006
    Date of Patent: January 10, 2017
    Assignee: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Frank Misselwitz, Dagmar Kubitza, Son-Mi Park, Klaus Wehling
  • Oxazolidinones For the Treatment and/or Prophylaxis of Heart Failure
    Publication number: 20110003804
    Abstract: The present invention relates to the use of selective inhibitors of coagulation factor Xa, in particular of oxazolidinones of the formula (I), for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure as well as their use for the preparation of pharmaceutical drugs for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure.
    Type: Application
    Filed: December 3, 2008
    Publication date: January 6, 2011
    Inventors: Harald Kallabis, Wolfgang Thielemann, Elisabeth Perzborn, Susanne Röhrig, Dagmar Kubitza, Theodore Spiro, Lloyd Haskell, Jeet Mahal
  • Prevention and Treatment of Thromboembolic Disorders
    Publication number: 20090004265
    Abstract: The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less.
    Type: Application
    Filed: January 19, 2006
    Publication date: January 1, 2009
    Applicant: BAYER HEALTHCARE AG
    Inventors: Frank Misselwitz, Dagmar Kubitza, Son-Mi Park, Klaus Wehling